Kenvue Inc. $KVUE Shares Sold by Envestnet Portfolio Solutions Inc.

Envestnet Portfolio Solutions Inc. lowered its position in Kenvue Inc. (NYSE:KVUE) by 54.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 135,733 shares of the company’s stock after selling 165,498 shares during the quarter. Envestnet Portfolio Solutions Inc.’s holdings in Kenvue were worth $2,203,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also modified their holdings of the company. Salomon & Ludwin LLC purchased a new stake in Kenvue in the 3rd quarter valued at $25,000. NBT Bank N A NY grew its position in Kenvue by 180.3% during the 3rd quarter. NBT Bank N A NY now owns 1,564 shares of the company’s stock worth $25,000 after purchasing an additional 1,006 shares during the last quarter. Trust Co. of Vermont increased its stake in Kenvue by 266.8% in the second quarter. Trust Co. of Vermont now owns 1,581 shares of the company’s stock valued at $33,000 after purchasing an additional 1,150 shares during the period. New England Capital Financial Advisors LLC raised its holdings in shares of Kenvue by 81.4% in the third quarter. New England Capital Financial Advisors LLC now owns 2,563 shares of the company’s stock valued at $42,000 after buying an additional 1,150 shares during the last quarter. Finally, Future Financial Wealth Managment LLC acquired a new position in Kenvue in the 3rd quarter valued at about $49,000. 97.64% of the stock is owned by institutional investors and hedge funds.

Kenvue Trading Down 1.0%

Shares of Kenvue stock opened at $17.63 on Tuesday. The company has a 50-day moving average of $17.08 and a two-hundred day moving average of $18.11. Kenvue Inc. has a 12-month low of $14.02 and a 12-month high of $25.17. The company has a current ratio of 0.98, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66. The stock has a market cap of $33.78 billion, a PE ratio of 23.51 and a beta of 0.60.

Kenvue (NYSE:KVUE) last released its quarterly earnings results on Monday, November 3rd. The company reported $0.28 earnings per share for the quarter, topping analysts’ consensus estimates of $0.27 by $0.01. Kenvue had a return on equity of 20.02% and a net margin of 9.55%.The business had revenue of $3.76 billion for the quarter, compared to analysts’ expectations of $3.83 billion. During the same quarter in the prior year, the firm posted $0.28 EPS. The company’s revenue was down 3.5% compared to the same quarter last year. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. On average, research analysts anticipate that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, November 26th. Stockholders of record on Wednesday, November 12th were given a $0.2075 dividend. The ex-dividend date was Wednesday, November 12th. This represents a $0.83 dividend on an annualized basis and a dividend yield of 4.7%. Kenvue’s dividend payout ratio (DPR) is currently 110.67%.

Wall Street Analysts Forecast Growth

KVUE has been the subject of a number of recent research reports. Jefferies Financial Group decreased their price objective on Kenvue from $25.00 to $23.00 and set a “buy” rating for the company in a research report on Monday, October 27th. Weiss Ratings restated a “hold (c-)” rating on shares of Kenvue in a research note on Friday, January 9th. Evercore ISI set a $18.00 target price on shares of Kenvue in a report on Tuesday, October 28th. Zacks Research upgraded shares of Kenvue from a “strong sell” rating to a “hold” rating in a research report on Wednesday, November 26th. Finally, UBS Group lowered their price objective on Kenvue from $23.00 to $17.00 and set a “neutral” rating on the stock in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and twelve have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Kenvue has an average rating of “Hold” and an average price target of $20.23.

Insider Activity

In other news, Director Jeffrey C. Smith purchased 3,200,000 shares of the business’s stock in a transaction dated Friday, December 12th. The stock was acquired at an average price of $17.37 per share, with a total value of $55,584,000.00. Following the purchase, the director directly owned 27,307,632 shares of the company’s stock, valued at $474,333,567.84. This represents a 13.27% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.17% of the stock is owned by company insiders.

Kenvue Profile

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.